Acetaldehyde

Acetaldehyde

SCHEMBL10068372

[3H]C(C)=O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetaldehyde SCHEMBL6747 0.72
Acetaldehyde SCHEMBL1330497 0.72
Acetaldehyde SCHEMBL2338299 0.72
Acetaldehyde SCHEMBL20411618 0.72
Acetaldehyde SCHEMBL1331732 0.72
Acetaldehyde SCHEMBL3945841 0.72
Acetaldehyde SCHEMBL25291303 0.67
Acetaldehyde SCHEMBL6758497 0.67
Acetaldehyde SCHEMBL2384792 0.67
Acetaldehyde SCHEMBL20658915 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140051723-A1 DEUTERATED N-ETHYL-N-PHENYL-1,2-DIHYDRO-4-HYDROXY-5-CHLORO-1-METHYL-2-OXOQUINOLINE-3-CARBOXAMIDE, SALTS AND USES THEREOF TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) 2014-02-20 US disclosed
US-8642141-B2 Liquid crystal composition, liquid crystal element, and liquid crystal display device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-02-04 US disclosed
US-8580819-B2 Deuterated N-ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2013-11-12 US disclosed
US-8563777-B2 Ionizable isotopic labeling reagents for relative quantification by mass spectrometry WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2013-10-22 US disclosed
US-8557994-B2 Deuterium-enriched pyridinonecarboxamides and derivatives DHANOA DALJIT SINGH (US) 2013-10-15 US disclosed
US-20130203706-A1 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-08-08 US disclosed
US-8501854-B2 Templated metal oxide particles and methods of making 3M INNOVATIVE PROPERTIES COMPANY (US) 2013-08-06 US disclosed
US-20130165494-A1 1,5-Diaryl-2-alkylpyrrole-3-Substituted Nitro Esters, Selective COX-2 Inhibitors and Nitric Oxide Donors ROTTAPHARM S.P.A. (IT) 2013-06-27 US disclosed
US-20130122516-A1 DETECTING TARGETS USING MASS TAGS AND MASS SPECTROMETRY VENTANA MEDICAL SYSTEMS, INC. 2013-05-16 US disclosed
US-20130109757-A1 PROCESS FOR THE PREPARATION OF PYRROLINES FROM GAMMA-NITROKETONES. USE OF THE GAMMA-NITROKETONES AS PESTICIDAL AGENTS BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-05-02 US disclosed
US-7579334-B2 Compounds with anti-inflammatory activity GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB (HR) 2009-08-25 US disclosed
US-20090176776-A1 SMALL MOLECULE INHIBITORS OF HIV-1 CAPSID ASSEMBLY UNIVERSITY OF ALABAMA AT BIRMINGHAM (US) 2009-07-09 US disclosed
US-7371779-B2 Synergistic compositions of N-acylhomoserine lactones and 4-quinolones THE SECRETARY OF STATE FOR DEFENSE SCIENCE AND TECHNOLOGY (GB) 2008-05-13 US disclosed
US-20080096830-A1 Anti-Inflammatory Macrolide Conjugates GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) 2008-04-24 US disclosed
US-20080090803-A1 FATTY ALCOHOL DRUG CONJUGATES LUITPOLD PHARMACEUTICALS, INC. (US) 2008-04-17 US disclosed
US-20080081807-A1 Arylphenyl-substituted cyclic keto-enols LIEB FOLKER 2008-04-03 US disclosed
US-20080050833-A1 Ionizable isotopic labeling reagents for relative quantification by mass spectrometry THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 2008-02-28 US disclosed
US-7323536-B2 Reaction product obtained by melt blending an aromatic polyester-polycarbonate and a transesterification catalyst that has a haze of less than 5.0% GENERAL ELECTRIC COMPANY (US) 2008-01-29 US disclosed
US-7320984-B2 Remedies or preventives for urinary frequency or urinary incontinence and morphinan derivatives having nitrogen-containing heterocyclic group TORAY INDUSTRIES, INC. (JP) 2008-01-22 US disclosed
US-20070015757-A1 Novel Glucagon Antagonists/Inverse Agonists NOVO NORDISK A/S (DK) 2007-01-18 US disclosed